eligibility for clinicaltrials:NCT01398306 [clinicaltrials_resource:e55b67dcc2354ed04925c0d50237f347]
eligibility [clinicaltrials_vocabulary:eligibility]
eligibility for clinicaltrials:NCT01398306 [clinicaltrials_resource:e55b67dcc2354ed04925c0d50237f347]
Bio2RDF identifier
e55b67dcc2354ed04925c0d50237f347
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:e55b67dcc2354ed04925c0d50237f347
exclusion criteria [clinicaltrials_vocabulary:exclusion-criteria]
gender [clinicaltrials_vocabulary:gender]
healthy volunteers [clinicaltrials_vocabulary:healthy-volunteers]
inclusion criteria [clinicaltrials_vocabulary:inclusion-criteria]
minimum age [clinicaltrials_vocabulary:minimum-age]
study population [clinicaltrials_vocabulary:study-population]
Patients with clear cell renal ...... crine tumours with metastases.
text [clinicaltrials_vocabulary:text]
Inclusion Criteria:
...... h a second primary malignancy.
identifier
clinicaltrials_resource:e55b67dcc2354ed04925c0d50237f347
title
eligibility for clinicaltrials:NCT01398306
@en
type
label
eligibility for clinicaltrials ...... b67dcc2354ed04925c0d50237f347]
@en